Artelo Biosciences, Inc. (ARTL) DCF Valuation

Artelo Biosciences, Inc. (ARTL) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Artelo Biosciences, Inc. (ARTL) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Evaluate the financial outlook of Artelo Biosciences, Inc. (ARTL) with expert precision! This (ARTL) DCF Calculator provides you with pre-filled financial data and the freedom to modify revenue growth, WACC, margins, and other essential assumptions to align with your projections.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2018		 AY2
2019		 AY3
2020		 AY4
2021		 AY5
2022		 FY1
2023		 FY2
2024		 FY3
2025		 FY4
2026		 FY5
2027
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -2.3 -4.2 -4.7 -7.4 -10.3 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -2.3 -4.2 -4.7 -7.4 -10.3 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash .3 4.4 2.1 10.1 17.5 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .5 .3 .5 .5 .9 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 -1.5 .0 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 2.07 2.07 2.07 2.07 2.07 2.07 2.07 2.07 2.07 2.07
EBITAT -2.3 -4.2 -4.7 -7.4 -10.1 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -1.8 -5.9 -4.6 -7.4 -9.7 -.9 .0 .0 .0 .0
WACC, % 10.76 10.76 10.76 10.76 10.76 10.76 10.76 10.76 10.76 10.76
PV UFCF
SUM PV UFCF -.8
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -1
Net Debt -7
Equity Value 6
Diluted Shares Outstanding, MM 3
Equity Value Per Share 2.12

What You Will Get

  • Editable Forecast Inputs: Easily modify assumptions (growth %, margins, WACC) to create various scenarios.
  • Real-World Data: Artelo Biosciences, Inc. (ARTL) financial data pre-filled to kickstart your analysis.
  • Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value for you.
  • Customizable and Professional: A sleek Excel model that adapts to your valuation requirements.
  • Built for Analysts and Investors: Perfect for testing projections, validating strategies, and enhancing efficiency.

Key Features

  • 🔍 Real-Life ARTL Financials: Pre-filled historical and projected data for Artelo Biosciences, Inc. (ARTL).
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Artelo’s intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Artelo’s valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  1. Step 1: Download the Excel file for Artelo Biosciences, Inc. (ARTL).
  2. Step 2: Review Artelo’s pre-filled financial data and projections.
  3. Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
  4. Step 4: Observe the DCF model update in real-time as you modify your assumptions.
  5. Step 5: Evaluate the outputs and leverage the results for informed investment choices.

Why Choose This Calculator?

  • User-Friendly Interface: Perfect for both novices and seasoned professionals.
  • Customizable Inputs: Adjust variables to suit your financial model and analysis.
  • Real-Time Valuation: Witness immediate updates to Artelo Biosciences' valuation as you change inputs.
  • Preloaded Data: Comes equipped with Artelo's latest financial information for swift evaluations.
  • Relied Upon by Experts: Favored by investors and analysts for making well-informed choices.

Who Should Use Artelo Biosciences, Inc. (ARTL)?

  • Investors: Gain insights into innovative biotech solutions and make informed investment choices.
  • Healthcare Analysts: Utilize comprehensive data to analyze market trends and company performance.
  • Consultants: Easily tailor presentations or reports on biotech advancements for clients.
  • Biotech Enthusiasts: Expand your knowledge of cutting-edge therapies and their potential impact.
  • Educators and Students: Leverage real-world case studies in biotechnology for academic purposes.

What the Template Contains

  • Historical Data: Includes Artelo Biosciences, Inc.'s (ARTL) past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate Artelo Biosciences, Inc.'s (ARTL) intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital specific to Artelo Biosciences, Inc. (ARTL).
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions for Artelo Biosciences, Inc. (ARTL).
  • Quarterly and Annual Statements: A complete breakdown of Artelo Biosciences, Inc.'s (ARTL) financials.
  • Interactive Dashboard: Visualize valuation results and projections for Artelo Biosciences, Inc. (ARTL) dynamically.

No products were found matching.